Blog
RSS FeedPosted by Michael Wonder on 28 Feb 2017
New Zealand Pharmaceutical Schedule - 1 March 2017
1 March 2017 - The March 2017 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 27 Feb 2017
Forget the banks – health insurance makes them look like amateurs
27 February 2017 - More Australian than hot summers and bagging cricket selectors is the habit of criticising the Big ...
Posted by Michael Wonder on 27 Feb 2017
Additional listings on the Pharmaceutical Schedule of a range of orthopaedic implants and associated products with Smith and Nephew Limited
27 February 2017 - PHARMAC is pleased to announce the approval of an amendment to the trauma agreement with Smith ...
Posted by Michael Wonder on 26 Feb 2017
All high earners to pay Medicare levy surcharge under budget proposal
27 February 2017 - All high-income Australians would pay the 1 to 1.5 per cent Medicare levy surcharge under a ...
Posted by Michael Wonder on 25 Feb 2017
Without rare-disease policy, patients in Canada face steep costs for drugs
24 February 2017 - Alex Chiabai has been living with the effects of Duchenne muscular dystrophy, a genetic disease that weakens ...
Posted by Michael Wonder on 25 Feb 2017
How much Australians spend on health
25 February 2017 - Personal spending on health is about $28.6 billion a year in Australia. ...
Posted by Michael Wonder on 25 Feb 2017
The importance of Swiss-style claims in Australia
24 February 2017 - The Federal Court has recently issued a decision that highlights the importance of including Swiss-style claims ...
Posted by Michael Wonder on 22 Feb 2017
Deal reduces price of life-saving hepatitis C drugs for Canadians
21 February 2017 - Tens of thousands of Canadian patients with mild versions of chronic hepatitis C could soon receive ...
Posted by Michael Wonder on 21 Feb 2017
NICE publishes draft guidance for eluxadoline
21 February 2017 - The Department of Health has asked NICE to produce guidance on using eluxadoline in the NHS in ...
Posted by Michael Wonder on 21 Feb 2017
Massive support for NZ drug-buying agency PHARMAC to fund pads and tampons
21 February 2017 - Nearly 10,000 people have responded to a 1 NEWS Facebook poll that asked if tampons and sanitary ...
Posted by Michael Wonder on 21 Feb 2017
NICE draft guidelines reject Ipsen’s Cabometyx
21 February 2017 - NICE has issued its first draft guidelines on Ipsen's Cabometyx, recommending against the drug's routine use ...
Posted by Michael Wonder on 20 Feb 2017
Australia is on target to eliminate hepatitis C by 2026
20 February 2017 - More than 30,000 hepatitis C patients in Australia have been treated with revolutionary drugs since their listing ...
Posted by Michael Wonder on 20 Feb 2017
Big pharma funding biases drug trials in favour of a sponsor's product: review
21 February 2017 - Drug and device trial studies that are sponsored by the pharmaceutical industry are more likely to ...
Posted by Michael Wonder on 20 Feb 2017
PHARMAC considers funding women's hygiene products
20 February 2017 - PHARMAC is considering funding women's hygiene products as the cost leaves some resorting to rags and ...
Posted by Michael Wonder on 19 Feb 2017
Public hospital funding crisis highlights need for reforms
17 February 2017 - The AMA public hospital report card released today highlights that our hospitals and broader health system ...